Droxidopa Therapy

Droxidopa Therapy is a pharmacological intervention involving the administration of droxidopa, a prodrug of norepinephrine, to ameliorate neurogenic orthostatic hypotension by augmenting sympathetic vasoconstrictor tone.

32

Publications

1.7K

Citations

104

Authors

52

Institutions

Publications per year

2017–2026

8

Publications

32

Authors

104

  1. LA
    L. Arthur Hewitt

    Lundbeck (United States), United States

    9 publications · 869 citations

    9

    h-index

  2. HK
    Horacio Kaufmann

    New York University, United States

    7 publications · 714 citations

    7

    h-index

  3. IB
    Italo Biaggioni

    Vanderbilt University, United States

    7 publications · 582 citations

    7

    h-index

  4. SI
    Stuart Isaacson

    Parkinson's Research and Education Foundation, United States

    6 publications · 390 citations

    6

    h-index

  5. GJ
    Gerald J. Rowse

    Mayo Clinic in Arizona, United States

    5 publications · 237 citations

    5

    h-index

1–5 of 104

Venues

  1. Clinical Autonomic Research

    3 publications · 175 citations

    3

    h-index

  2. Journal of the American Society of Hypertension

    JASH · 2 publications · 52 citations

    2

    h-index

  3. Neurology

    2 publications · 314 citations

    2

    h-index

  4. Journal of Parkinson s Disease

    2 publications · 139 citations

    2

    h-index

  5. Movement Disorders Clinical Practice

    MDCP · 2 publications · 35 citations

    2

    h-index

1–5